Process View
The aggregation and bonding together of a set of components to form a focal adhesion, a complex of intracellular signaling and structural proteins that provides a structural link between the internal actin cytoskeleton and the ECM, and also function as a locus of signal transduction activity.

In addition to gene-name show these genes:
Click on a gene's description to view its network relationships with genes known to be involved in "focal adhesion assembly"
| Name | Description | Probability | Func Analog Organism | |
|---|---|---|---|---|
| PDGFRA | platelet-derived growth factor receptor, alpha polypeptide | 0.998 | Human | |
| CDC42 | cell division cycle 42 (GTP binding protein, 25kDa) | 0.998 | Human | |
| FLT1 | fms-related tyrosine kinase 1 (vascular endothelial growth factor/vascular permeability factor receptor) | 0.997 | Human | |
| PDGFRB | platelet-derived growth factor receptor, beta polypeptide | 0.985 | Human | |
| VEGFA | vascular endothelial growth factor A | 0.980 | ||
| KDR | kinase insert domain receptor (a type III receptor tyrosine kinase) | 0.964 | ||
| NRP1 | neuropilin 1 | 0.887 | ||
| MLLT4 | myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila); translocated to, 4 | 0.882 | ||
| S100A6 | S100 calcium binding protein A6 | 0.866 | Human | |
| S100A9 | S100 calcium binding protein A9 | 0.856 | Human | |
| S100A8 | S100 calcium binding protein A8 | 0.836 | Human | |
| FYN | FYN oncogene related to SRC, FGR, YES | 0.833 | ||
| S100B | S100 calcium binding protein B | 0.791 | Human | |
| PTK2 | PTK2 protein tyrosine kinase 2 | 0.778 | ||
| GRB7 | growth factor receptor-bound protein 7 | 0.736 | ||
| PDGFB | platelet-derived growth factor beta polypeptide (simian sarcoma viral (v-sis) oncogene homolog) | 0.707 | Human | |
| CRKL | v-crk sarcoma virus CT10 oncogene homolog (avian)-like | 0.685 | ||
| RAC1 | ras-related C3 botulinum toxin substrate 1 (rho family, small GTP binding protein Rac1) | 0.530 | ||
| MDM2 | Mdm2 p53 binding protein homolog (mouse) | 0.526 | ||
| ZYX | zyxin | 0.525 | ||
| S100A1 | S100 calcium binding protein A1 | 0.506 | Human | |
| EPHA2 | EPH receptor A2 | 0.486 | Human | |
| CDH5 | cadherin 5, type 2 (vascular endothelium) | 0.482 | ||
| SMAD2 | SMAD family member 2 | 0.476 | ||
| ENG | endoglin | 0.457 | ||
| LATS2 | LATS, large tumor suppressor, homolog 2 (Drosophila) | 0.454 | ||
| S100A11 | S100 calcium binding protein A11 | 0.450 | Human | |
| BMP2 | bone morphogenetic protein 2 | 0.380 | ||
| ANGPT2 | angiopoietin 2 | 0.362 | ||
| BMPR2 | bone morphogenetic protein receptor, type II (serine/threonine kinase) | 0.357 | Human | |
| TCF4 | transcription factor 4 | 0.352 | ||
| NCK2 | NCK adaptor protein 2 | 0.335 | ||
| S100A4 | S100 calcium binding protein A4 | 0.320 | Human | |
| EFNA1 | ephrin-A1 | 0.304 | Human | |
| VCL | vinculin | 0.296 | ||
| PLCG1 | phospholipase C, gamma 1 | 0.280 | ||
| SKIL | SKI-like oncogene | 0.279 | ||
| PVRL1 | poliovirus receptor-related 1 (herpesvirus entry mediator C) | 0.279 | ||
| TRIP6 | thyroid hormone receptor interactor 6 | 0.236 | ||
| TGFBR2 | transforming growth factor, beta receptor II (70/80kDa) | 0.232 | Human | |
| ARHGDIB | Rho GDP dissociation inhibitor (GDI) beta | 0.206 | ||
| EPHA7 | EPH receptor A7 | 0.206 | Human | |
| PDGFA | platelet-derived growth factor alpha polypeptide | 0.191 | Human | |
| CAV1 | caveolin 1, caveolae protein, 22kDa | 0.191 | ||
| SH3KBP1 | SH3-domain kinase binding protein 1 | 0.190 | ||
| CRK | v-crk sarcoma virus CT10 oncogene homolog (avian) | 0.188 | ||
| PTPRB | protein tyrosine phosphatase, receptor type, B | 0.174 | Human | |
| SRC | v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian) | 0.169 | Rat | |
| TGFB3 | transforming growth factor, beta 3 | 0.151 | ||
| LIMS1 | LIM and senescent cell antigen-like domains 1 | 0.149 | ||
| PAG1 | phosphoprotein associated with glycosphingolipid microdomains 1 | 0.144 | ||
| EFNA5 | ephrin-A5 | 0.139 | ||
| ITGB1 | integrin, beta 1 (fibronectin receptor, beta polypeptide, antigen CD29 includes MDF2, MSK12) | 0.138 | ||
| TSG101 | tumor susceptibility gene 101 | 0.134 | ||
| CTNND1 | catenin (cadherin-associated protein), delta 1 | 0.131 | ||
| BCAR1 | breast cancer anti-estrogen resistance 1 | 0.130 | ||
| ILK | integrin-linked kinase | 0.128 | ||
| TEK | TEK tyrosine kinase, endothelial | 0.127 | ||
| SFN | stratifin | 0.126 | ||
| CDH1 | cadherin 1, type 1, E-cadherin (epithelial) | 0.117 | ||
| GIT1 | G protein-coupled receptor kinase interacting ArfGAP 1 | 0.115 | ||
| BCL2L1 | BCL2-like 1 | 0.111 | ||
| PDGFC | platelet derived growth factor C | 0.109 | ||
| ANGPT1 | angiopoietin 1 | 0.108 | ||
| GIT2 | G protein-coupled receptor kinase interacting ArfGAP 2 | 0.102 | ||
| GDF5 | growth differentiation factor 5 | 0.100 | ||
| ANXA2 | annexin A2 | 0.097 | ||
| RHOU | ras homolog gene family, member U | 0.096 | ||
| PGF | placental growth factor | 0.096 | Human | |
| CALD1 | caldesmon 1 | 0.094 | ||
| ARHGEF7 | Rho guanine nucleotide exchange factor (GEF) 7 | 0.094 | ||
| LPXN | leupaxin | 0.094 | Human | |
| CTNNA1 | catenin (cadherin-associated protein), alpha 1, 102kDa | 0.092 | ||
| SEMA6A | sema domain, transmembrane domain (TM), and cytoplasmic domain, (semaphorin) 6A | 0.091 | ||
| TJP1 | tight junction protein 1 (zona occludens 1) | 0.083 | ||
| CAPG | capping protein (actin filament), gelsolin-like | 0.082 | ||
| COL4A1 | collagen, type IV, alpha 1 | 0.081 | ||
| COL4A2 | collagen, type IV, alpha 2 | 0.080 | ||
| PVRL2 | poliovirus receptor-related 2 (herpesvirus entry mediator B) | 0.077 | ||
| KCNA5 | potassium voltage-gated channel, shaker-related subfamily, member 5 | 0.073 | ||
| SMAD7 | SMAD family member 7 | 0.072 | ||
| MET | met proto-oncogene (hepatocyte growth factor receptor) | 0.070 | ||
| FXYD5 | FXYD domain containing ion transport regulator 5 | 0.066 | ||
| MAGI3 | membrane associated guanylate kinase, WW and PDZ domain containing 3 | 0.066 | ||
| SNAI1 | snail homolog 1 (Drosophila) | 0.063 | ||
| AREG | amphiregulin | 0.062 | ||
| EPHB3 | EPH receptor B3 | 0.061 | Human | |
| SH3BGRL3 | SH3 domain binding glutamic acid-rich protein like 3 | 0.060 | ||
| PDLIM1 | PDZ and LIM domain 1 | 0.060 | ||
| PLP2 | proteolipid protein 2 (colonic epithelium-enriched) | 0.058 | ||
| RASA1 | RAS p21 protein activator (GTPase activating protein) 1 | 0.058 | ||
| CARD11 | caspase recruitment domain family, member 11 | 0.056 | ||
| ZMYND11 | zinc finger, MYND-type containing 11 | 0.056 | ||
| ATF7IP | activating transcription factor 7 interacting protein | 0.055 | ||
| FLNA | filamin A, alpha | 0.053 | ||
| HOXA1 | homeobox A1 | 0.053 | ||
| MYOZ1 | myozenin 1 | 0.053 | ||
| PTPN1 | protein tyrosine phosphatase, non-receptor type 1 | 0.051 | ||
| FKBP1A | FK506 binding protein 1A, 12kDa | 0.051 | ||
| SH2D1A | SH2 domain containing 1A | 0.051 | ||
| PRKG1 | protein kinase, cGMP-dependent, type I | 0.051 | ||
| EMP3 | epithelial membrane protein 3 | 0.051 | ||
| KITLG | KIT ligand | 0.051 | ||
| PTPRJ | protein tyrosine phosphatase, receptor type, J | 0.050 | ||
| TIE1 | tyrosine kinase with immunoglobulin-like and EGF-like domains 1 | 0.049 | Human | |
| TIMP1 | TIMP metallopeptidase inhibitor 1 | 0.049 | ||
| RAMP2 | receptor (G protein-coupled) activity modifying protein 2 | 0.049 | ||
| SHC1 | SHC (Src homology 2 domain containing) transforming protein 1 | 0.048 | ||
| S100A2 | S100 calcium binding protein A2 | 0.047 | Human | |
| BMPR1A | bone morphogenetic protein receptor, type IA | 0.046 | Human | |
| FN1 | fibronectin 1 | 0.045 | ||
| FURIN | furin (paired basic amino acid cleaving enzyme) | 0.043 | ||
| MSN | moesin | 0.042 | ||
| GRB10 | growth factor receptor-bound protein 10 | 0.041 | ||
| TLN1 | talin 1 | 0.041 | ||
| TMSB10 | thymosin beta 10 | 0.040 | ||
| FAF1 | Fas (TNFRSF6) associated factor 1 | 0.039 | ||
| AGER | advanced glycosylation end product-specific receptor | 0.038 | ||
| FKBP4 | FK506 binding protein 4, 59kDa | 0.038 | ||
| RRAS | related RAS viral (r-ras) oncogene homolog | 0.038 | ||
| LGALS3 | lectin, galactoside-binding, soluble, 3 | 0.038 | ||
| CAV2 | caveolin 2 | 0.038 | ||
| BMP1 | bone morphogenetic protein 1 | 0.037 | ||
| RHOC | ras homolog gene family, member C | 0.037 | ||
| DIAPH1 | diaphanous homolog 1 (Drosophila) | 0.037 | ||
| HTT | huntingtin | 0.036 | ||
| GAB1 | GRB2-associated binding protein 1 | 0.036 | ||
| MMP1 | matrix metallopeptidase 1 (interstitial collagenase) | 0.036 | ||
| CHD3 | chromodomain helicase DNA binding protein 3 | 0.035 | ||
| EPHA3 | EPH receptor A3 | 0.035 | ||
| PTRF | polymerase I and transcript release factor | 0.035 | ||
| CD34 | CD34 molecule | 0.034 | ||
| IKBKB | inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase beta | 0.034 | ||
| SORBS2 | sorbin and SH3 domain containing 2 | 0.034 | ||
| CDC42EP3 | CDC42 effector protein (Rho GTPase binding) 3 | 0.034 | ||
| PARVA | parvin, alpha | 0.034 | ||
| BBS10 | Bardet-Biedl syndrome 10 | 0.034 | ||
| CD248 | CD248 molecule, endosialin | 0.034 | ||
| BMP4 | bone morphogenetic protein 4 | 0.033 | ||
| CD63 | CD63 molecule | 0.033 | ||
| TGFB2 | transforming growth factor, beta 2 | 0.033 | ||
| PIK3R1 | phosphoinositide-3-kinase, regulatory subunit 1 (alpha) | 0.033 | ||
| LGALS1 | lectin, galactoside-binding, soluble, 1 | 0.032 | ||
| DPYSL4 | dihydropyrimidinase-like 4 | 0.032 | ||
| S100A10 | S100 calcium binding protein A10 | 0.032 | ||
| ANGPTL2 | angiopoietin-like 2 | 0.032 | ||
| MATK | megakaryocyte-associated tyrosine kinase | 0.031 | ||
| MAPK8 | mitogen-activated protein kinase 8 | 0.031 | ||
| ZNF746 | zinc finger protein 746 | 0.029 | ||
| JUP | junction plakoglobin | 0.029 | ||
| CDC42EP1 | CDC42 effector protein (Rho GTPase binding) 1 | 0.029 | ||
| NRP2 | neuropilin 2 | 0.028 | ||
| MAP2K3 | mitogen-activated protein kinase kinase 3 | 0.028 | ||
| CSNK1D | casein kinase 1, delta | 0.028 | ||
| FLT4 | fms-related tyrosine kinase 4 | 0.028 | Human | |
| PXN | paxillin | 0.028 | Human Mouse | |
| CDKN2A | cyclin-dependent kinase inhibitor 2A (melanoma, p16, inhibits CDK4) | 0.027 | ||
| COL6A1 | collagen, type VI, alpha 1 | 0.027 | ||
| MYO9B | myosin IXB | 0.027 | ||
| MAP3K11 | mitogen-activated protein kinase kinase kinase 11 | 0.026 | ||
| ERBB2 | v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog (avian) | 0.025 | ||
| MMP16 | matrix metallopeptidase 16 (membrane-inserted) | 0.025 | ||
| ITGA5 | integrin, alpha 5 (fibronectin receptor, alpha polypeptide) | 0.025 | ||
| ADRBK1 | adrenergic, beta, receptor kinase 1 | 0.025 | ||
| IQGAP1 | IQ motif containing GTPase activating protein 1 | 0.025 | ||
| TSC2 | tuberous sclerosis 2 | 0.025 | ||
| JAG1 | jagged 1 | 0.024 | ||
| CDKN1A | cyclin-dependent kinase inhibitor 1A (p21, Cip1) | 0.024 | ||
| LAMB3 | laminin, beta 3 | 0.024 | ||
| COTL1 | coactosin-like 1 (Dictyostelium) | 0.024 | ||
| CNKSR1 | connector enhancer of kinase suppressor of Ras 1 | 0.024 | ||
| TIMP3 | TIMP metallopeptidase inhibitor 3 | 0.024 | ||
| COL5A1 | collagen, type V, alpha 1 | 0.024 | ||
| PHF21A | PHD finger protein 21A | 0.024 | ||
| DISC1 | disrupted in schizophrenia 1 | 0.024 | ||
| ROBO4 | roundabout homolog 4, magic roundabout (Drosophila) | 0.024 | ||
| CRIM1 | cysteine rich transmembrane BMP regulator 1 (chordin-like) | 0.023 | ||
| SORBS3 | sorbin and SH3 domain containing 3 | 0.023 | ||
| ACVR1 | activin A receptor, type I | 0.023 | Human | |
| SPARCL1 | SPARC-like 1 (hevin) | 0.023 | ||
| SEMA3F | sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3F | 0.023 | ||
| KIAA1377 | KIAA1377 | 0.022 | ||
| PRKCDBP | protein kinase C, delta binding protein | 0.022 | ||
| DDR1 | discoidin domain receptor tyrosine kinase 1 | 0.022 | ||
| S100A12 | S100 calcium binding protein A12 | 0.022 | Human | |
| STK10 | serine/threonine kinase 10 | 0.022 | ||
| GPRASP2 | G protein-coupled receptor associated sorting protein 2 | 0.022 | ||
| PITPNM1 | phosphatidylinositol transfer protein, membrane-associated 1 | 0.022 | ||
| PTPRD | protein tyrosine phosphatase, receptor type, D | 0.022 | Human | |
| MOBKL1A | MOB1, Mps One Binder kinase activator-like 1A (yeast) | 0.022 | ||
| GIPC1 | GIPC PDZ domain containing family, member 1 | 0.022 | ||
| PRRX1 | paired related homeobox 1 | 0.021 | ||
| APC | adenomatous polyposis coli | 0.021 | ||
| LDLR | low density lipoprotein receptor | 0.021 | ||
| PHC2 | polyhomeotic homolog 2 (Drosophila) | 0.021 | ||
| STK4 | serine/threonine kinase 4 | 0.021 | ||
| LAMA4 | laminin, alpha 4 | 0.021 | ||
| TCF7L2 | transcription factor 7-like 2 (T-cell specific, HMG-box) | 0.020 | ||
| AMOTL2 | angiomotin like 2 | 0.020 | ||
| DST | dystonin | 0.020 | ||
| CRYAB | crystallin, alpha B | 0.020 | ||
| GHR | growth hormone receptor | 0.020 | ||
| ERBB3 | v-erb-b2 erythroblastic leukemia viral oncogene homolog 3 (avian) | 0.019 | ||
| ZNF426 | zinc finger protein 426 | 0.019 | ||
| ACVR1B | activin A receptor, type IB | 0.019 | Human | |
| CNN2 | calponin 2 | 0.019 | ||
| VASP | vasodilator-stimulated phosphoprotein | 0.019 | ||
| HES1 | hairy and enhancer of split 1, (Drosophila) | 0.019 | ||
| PVRL3 | poliovirus receptor-related 3 | 0.019 | ||
| DAG1 | dystroglycan 1 (dystrophin-associated glycoprotein 1) | 0.019 | ||
| MYBPH | myosin binding protein H | 0.019 | ||
| PDE2A | phosphodiesterase 2A, cGMP-stimulated | 0.019 | ||
| PTPN23 | protein tyrosine phosphatase, non-receptor type 23 | 0.019 | ||
| TCAP | titin-cap (telethonin) | 0.019 | ||
| FBLIM1 | filamin binding LIM protein 1 | 0.019 | ||
| PPAP2B | phosphatidic acid phosphatase type 2B | 0.019 | ||
| PPBP | pro-platelet basic protein (chemokine (C-X-C motif) ligand 7) | 0.019 | ||
| KIAA1539 | KIAA1539 | 0.018 | ||
| TBC1D1 | TBC1 (tre-2/USP6, BUB2, cdc16) domain family, member 1 | 0.018 | ||
| PLXND1 | plexin D1 | 0.018 | ||
| COL1A1 | collagen, type I, alpha 1 | 0.018 | ||
| EPHB2 | EPH receptor B2 | 0.018 | Human | |
| NEDD4L | neural precursor cell expressed, developmentally down-regulated 4-like | 0.018 | ||
| GNAI2 | guanine nucleotide binding protein (G protein), alpha inhibiting activity polypeptide 2 | 0.018 | ||
| LUM | lumican | 0.018 | ||
| FYB | FYN binding protein | 0.017 | ||
| NFAT5 | nuclear factor of activated T-cells 5, tonicity-responsive | 0.017 | ||
| GOLGB1 | golgin B1 | 0.017 | ||
| ITGA3 | integrin, alpha 3 (antigen CD49C, alpha 3 subunit of VLA-3 receptor) | 0.017 | ||
| LTBP2 | latent transforming growth factor beta binding protein 2 | 0.017 | ||
| SHC2 | SHC (Src homology 2 domain containing) transforming protein 2 | 0.017 | ||
| NTRK2 | neurotrophic tyrosine kinase, receptor, type 2 | 0.017 | ||
| ANTXR2 | anthrax toxin receptor 2 | 0.017 | ||
| BTRC | beta-transducin repeat containing | 0.017 | ||
| DLGAP4 | discs, large (Drosophila) homolog-associated protein 4 | 0.017 | ||
| RGS5 | regulator of G-protein signaling 5 | 0.017 | ||
| GJA4 | gap junction protein, alpha 4, 37kDa | 0.017 | ||
| VWF | von Willebrand factor | 0.017 | ||
| PNPLA6 | patatin-like phospholipase domain containing 6 | 0.016 | ||
| AHNAK | AHNAK nucleoprotein | 0.016 | ||
| TRIO | triple functional domain (PTPRF interacting) | 0.016 | ||
| PAWR | PRKC, apoptosis, WT1, regulator | 0.016 | ||
| LMO2 | LIM domain only 2 (rhombotin-like 1) | 0.016 | ||
| DLC1 | deleted in liver cancer 1 | 0.016 | Mouse | |
| PDCD6IP | programmed cell death 6 interacting protein | 0.016 | ||
| CSTA | cystatin A (stefin A) | 0.016 | ||
| PTN | pleiotrophin | 0.016 | ||
| WT1 | Wilms tumor 1 | 0.016 | ||
| HIPK3 | homeodomain interacting protein kinase 3 | 0.016 | ||
| LAMC2 | laminin, gamma 2 | 0.016 | ||
| COL1A2 | collagen, type I, alpha 2 | 0.016 | ||
| CSNK1E | casein kinase 1, epsilon | 0.016 | ||
| SMURF2 | SMAD specific E3 ubiquitin protein ligase 2 | 0.016 | ||
| C1orf93 | chromosome 1 open reading frame 93 | 0.016 | ||
| PKD2 | polycystic kidney disease 2 (autosomal dominant) | 0.015 | ||
| CRIPAK | cysteine-rich PAK1 inhibitor | 0.015 | ||
| AKT1 | v-akt murine thymoma viral oncogene homolog 1 | 0.015 | ||
| TSPO | translocator protein (18kDa) | 0.015 | ||
| EFNB1 | ephrin-B1 | 0.015 | Human | |
| PMEPA1 | prostate transmembrane protein, androgen induced 1 | 0.015 | ||
| PECAM1 | platelet/endothelial cell adhesion molecule | 0.015 | ||
| MMP2 | matrix metallopeptidase 2 (gelatinase A, 72kDa gelatinase, 72kDa type IV collagenase) | 0.015 | ||
| NCF2 | neutrophil cytosolic factor 2 | 0.015 | ||
| BGN | biglycan | 0.015 | ||
| MMRN2 | multimerin 2 | 0.015 | ||
| SKI | v-ski sarcoma viral oncogene homolog (avian) | 0.015 | ||
| TIMP2 | TIMP metallopeptidase inhibitor 2 | 0.015 | ||
| FAM129B | family with sequence similarity 129, member B | 0.014 | ||
| VAT1 | vesicle amine transport protein 1 homolog (T. californica) | 0.014 | ||
| MYH11 | myosin, heavy chain 11, smooth muscle | 0.014 | ||
| EFNB2 | ephrin-B2 | 0.014 | Human | |
| EPHA4 | EPH receptor A4 | 0.014 | Human | |
| AKAP12 | A kinase (PRKA) anchor protein 12 | 0.014 | ||
| COL18A1 | collagen, type XVIII, alpha 1 | 0.014 | ||
| SBF1 | SET binding factor 1 | 0.014 | ||
| FAM65A | family with sequence similarity 65, member A | 0.014 | ||
| CD9 | CD9 molecule | 0.014 | ||
| LAMC1 | laminin, gamma 1 (formerly LAMB2) | 0.014 | ||
| THBS1 | thrombospondin 1 | 0.014 | ||
| PTPRS | protein tyrosine phosphatase, receptor type, S | 0.014 | Human | |
| EMCN | endomucin | 0.014 | ||
| ID1 | inhibitor of DNA binding 1, dominant negative helix-loop-helix protein | 0.014 | ||
| MDFI | MyoD family inhibitor | 0.014 | ||
| SEPT11 | septin 11 | 0.014 | ||
| PLXDC1 | plexin domain containing 1 | 0.014 | ||
| SMTN | smoothelin | 0.013 | ||
| HSPG2 | heparan sulfate proteoglycan 2 | 0.013 | ||
| RHOG | ras homolog gene family, member G (rho G) | 0.013 | Human | |
| DOCK1 | dedicator of cytokinesis 1 | 0.013 | ||
| ITGA6 | integrin, alpha 6 | 0.013 | ||
| PSG5 | pregnancy specific beta-1-glycoprotein 5 | 0.013 | ||
| STC1 | stanniocalcin 1 | 0.013 | ||
| LMNA | lamin A/C | 0.013 | ||
| ATG14 | ATG14 autophagy related 14 homolog (S. cerevisiae) | 0.013 | ||
| TGFBR1 | transforming growth factor, beta receptor 1 | 0.013 | Human | |
| IGFBP5 | insulin-like growth factor binding protein 5 | 0.013 | ||
| PTPN21 | protein tyrosine phosphatase, non-receptor type 21 | 0.013 | ||
| CD97 | CD97 molecule | 0.013 | ||
| MRAS | muscle RAS oncogene homolog | 0.013 | ||
| SDC1 | syndecan 1 | 0.013 | ||
| MAP2 | microtubule-associated protein 2 | 0.013 | ||
| EPHB4 | EPH receptor B4 | 0.013 | Human | |
| LAMA5 | laminin, alpha 5 | 0.013 | ||
| SLCO2A1 | solute carrier organic anion transporter family, member 2A1 | 0.012 | ||
| INHBB | inhibin, beta B | 0.012 | ||
| AMBRA1 | autophagy/beclin-1 regulator 1 | 0.012 | ||
| NID2 | nidogen 2 (osteonidogen) | 0.012 | ||
| MMP19 | matrix metallopeptidase 19 | 0.012 | ||
| SOX11 | SRY (sex determining region Y)-box 11 | 0.012 | ||
| CSPG4 | chondroitin sulfate proteoglycan 4 | 0.012 | ||
| ZNF580 | zinc finger protein 580 | 0.012 | ||
| ATXN2 | ataxin 2 | 0.012 | ||
| PTPRF | protein tyrosine phosphatase, receptor type, F | 0.012 | Human | |
| SERPINE1 | serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1 | 0.012 | ||
| TBX2 | T-box 2 | 0.012 | ||
| NOTCH4 | notch 4 | 0.012 | ||
| RELN | reelin | 0.012 | ||
| S100P | S100 calcium binding protein P | 0.012 | Human | |
| CD44 | CD44 molecule (Indian blood group) | 0.012 | ||
| ZFYVE26 | zinc finger, FYVE domain containing 26 | 0.012 | ||
| RAC2 | ras-related C3 botulinum toxin substrate 2 (rho family, small GTP binding protein Rac2) | 0.012 | Human | |
| JAG2 | jagged 2 | 0.012 | ||
| MEF2A | myocyte enhancer factor 2A | 0.012 | ||
| KIAA1462 | KIAA1462 | 0.012 | ||
| ELF4 | E74-like factor 4 (ets domain transcription factor) | 0.012 | ||
| POM121 | POM121 membrane glycoprotein | 0.012 | ||
| CDH13 | cadherin 13, H-cadherin (heart) | 0.012 | ||
| SLA | Src-like-adaptor | 0.012 | ||
| BAK1 | BCL2-antagonist/killer 1 | 0.012 | ||
| FKBP8 | FK506 binding protein 8, 38kDa | 0.012 | ||
| DYNC1I1 | dynein, cytoplasmic 1, intermediate chain 1 | 0.012 | ||
| NCK1 | NCK adaptor protein 1 | 0.011 | ||
| GADD45G | growth arrest and DNA-damage-inducible, gamma | 0.011 | ||
| DEF6 | differentially expressed in FDCP 6 homolog (mouse) | 0.011 | ||
| GNL3L | guanine nucleotide binding protein-like 3 (nucleolar)-like | 0.011 | ||
| HGF | hepatocyte growth factor (hepapoietin A; scatter factor) | 0.011 | ||
| EPHB6 | EPH receptor B6 | 0.011 | Human | |
| RNPC3 | RNA-binding region (RNP1, RRM) containing 3 | 0.011 | ||
| MPDZ | multiple PDZ domain protein | 0.011 | ||
| ERBB2IP | erbb2 interacting protein | 0.011 | ||
| TMEM108 | transmembrane protein 108 | 0.011 | ||
| RBMS3 | RNA binding motif, single stranded interacting protein 3 | 0.011 | ||
| SLPI | secretory leukocyte peptidase inhibitor | 0.011 | ||
| EGFR | epidermal growth factor receptor | 0.011 | ||
| TMEM47 | transmembrane protein 47 | 0.011 | ||
| BTBD7 | BTB (POZ) domain containing 7 | 0.011 | ||
| PODXL | podocalyxin-like | 0.011 | ||
| GORAB | golgin, RAB6-interacting | 0.011 | ||
| F2R | coagulation factor II (thrombin) receptor | 0.011 | ||
| DOCK8 | dedicator of cytokinesis 8 | 0.011 | ||
| FAM110A | family with sequence similarity 110, member A | 0.011 | ||
| UNC119 | unc-119 homolog (C. elegans) | 0.011 | ||
| FZD7 | frizzled homolog 7 (Drosophila) | 0.011 | ||
| TUBB2A | tubulin, beta 2A | 0.011 | ||
| VEGFC | vascular endothelial growth factor C | 0.011 | Human | |
| ID4 | inhibitor of DNA binding 4, dominant negative helix-loop-helix protein | 0.011 | ||
| ARHGEF11 | Rho guanine nucleotide exchange factor (GEF) 11 | 0.011 | ||
| MCAM | melanoma cell adhesion molecule | 0.011 | ||
| IGFBP3 | insulin-like growth factor binding protein 3 | 0.011 | ||
| F3 | coagulation factor III (thromboplastin, tissue factor) | 0.011 | ||
| FES | feline sarcoma oncogene | 0.011 | ||
| CRABP2 | cellular retinoic acid binding protein 2 | 0.011 | ||
| PRKCQ | protein kinase C, theta | 0.011 | ||
| KIAA1217 | KIAA1217 | 0.011 | ||
| MCL1 | myeloid cell leukemia sequence 1 (BCL2-related) | 0.011 | ||
| PRELP | proline/arginine-rich end leucine-rich repeat protein | 0.011 | ||
| GPR116 | G protein-coupled receptor 116 | 0.011 | ||
| SOX9 | SRY (sex determining region Y)-box 9 | 0.011 | ||
| NUAK1 | NUAK family, SNF1-like kinase, 1 | 0.011 | ||
| LPPR2 | lipid phosphate phosphatase-related protein type 2 | 0.011 | ||
| EXT1 | exostosin 1 | 0.011 | ||
| ACTN2 | actinin, alpha 2 | 0.011 | ||
| LPP | LIM domain containing preferred translocation partner in lipoma | 0.011 | ||
| COL2A1 | collagen, type II, alpha 1 | 0.011 | ||
| MYCT1 | myc target 1 | 0.011 | ||
| DPPA4 | developmental pluripotency associated 4 | 0.011 | ||
| VCAM1 | vascular cell adhesion molecule 1 | 0.010 | ||
| LDB2 | LIM domain binding 2 | 0.010 | ||
| FEZ1 | fasciculation and elongation protein zeta 1 (zygin I) | 0.010 | ||
| PKN1 | protein kinase N1 | 0.010 | ||
| NCF4 | neutrophil cytosolic factor 4, 40kDa | 0.010 | ||
| KIAA1949 | KIAA1949 | 0.010 | ||
| COL4A3 | collagen, type IV, alpha 3 (Goodpasture antigen) | 0.010 | ||
| PERP | PERP, TP53 apoptosis effector | 0.010 | ||
| ENPEP | glutamyl aminopeptidase (aminopeptidase A) | 0.010 | ||
| HIPK2 | homeodomain interacting protein kinase 2 | 0.010 | ||
| COL5A3 | collagen, type V, alpha 3 | 0.010 | ||
| EFHD2 | EF-hand domain family, member D2 | 0.010 | ||
| SHB | Src homology 2 domain containing adaptor protein B | 0.010 | ||
| DVL1 | dishevelled, dsh homolog 1 (Drosophila) | 0.010 | ||
| FZD4 | frizzled homolog 4 (Drosophila) | 0.010 | ||
| ITGAV | integrin, alpha V (vitronectin receptor, alpha polypeptide, antigen CD51) | 0.010 | ||
| CTNNB1 | catenin (cadherin-associated protein), beta 1, 88kDa | 0.010 | ||
| MED15 | mediator complex subunit 15 | 0.010 |